BUSINESS AREA
GENERAL & ADMINISTRATIVE (G&A) SYSTEMS
As demands on support teams grow, we help them operate smarter.
General and Administrative (G&A) teams in life sciences face mounting expectations to do more with less – balancing cost control, compliance, and efficiency in regulated environments. Disconnected systems, manual processes, and evolving oversight requirements can strain already limited resources.
Our team of experts assist pharmaceutical G&A functions – including Finance, HR, Legal, Facilities, and Administration – enhance efficiency, compliance, and control through structured program management and process optimization. Our consultants bring extensive life sciences experience leading enterprise initiatives that align back-office operations with regulatory and business goals. By combining project leadership, process design, and compliance oversight, Osprey strengthens internal controls and audit readiness across G&A functions – enabling organizations to scale efficiently and maintain operational excellence.
Discover the impact we’ve made with our life sciences partners
Powering Enterprise-Scale Research Through a Custom Clinical Trial Platform
Gearing up for a pivotal BLA submission, sought to revolutionize its document management and regulatory transparency.
Transforming Competitive Insights into a Scalable, Governed Enterprise Capability
Gearing up for a pivotal BLA submission, sought to revolutionize its document management and regulatory transparency.
Strengthening Identity Governance Through a Compliant SailPoint Implementation
Gearing up for a pivotal BLA submission, sought to revolutionize its document management and regulatory transparency.
Industry trends, expert perspectives, and innovative solutions
Why Technology Buyers Struggle with Large Consulting Firms and Prefer High-Value Smaller Partners
Technology leaders face constant pressure to deliver solutions that are innovative, reliable, and tailored to the needs of the business. When seeking external expertise, many organizations instinctively turn to large consulting firms based on name recognition, global...
Top 5 Ways Life Sciences Companies Can Prepare for an FDA Inspection
As FDA resources tighten and regulatory expectations evolve, inspection readiness has never been more critical. Life sciences companies – whether in pharmaceuticals, biotech, or medical devices – must take a proactive and structured approach to ensure they are...
Measuring the Impact of FDA Personnel Cuts in 2025
How Staff Reductions Are Disrupting Drug Reviews and Regulatory Oversight The 2025 FDA personnel cuts are already sending shockwaves through the drug approval pipeline, with mounting evidence that reduced staffing is compromising both the speed and integrity of...






